A Clinical Trial of TQB3909 Tablets in Subjects With Advanced Malignant Tumors

NCT04975204 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

126

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignant Tumor

Interventions

DRUG: TQB3909 Tablets

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.